| FHIR-45328 |
Tag bundles to identify which use case is being reported |
| FHIR-45327 |
Support Catchment Area |
| FHIR-44524 |
Revise Introduction to include other approaches than MedMorph RA |
| FHIR-44516 |
Clarify sections included in profile content table and not in the Intro section |
| FHIR-44513 |
Revise workflow to incorporate De-Identification and use UDS+ approach |
| FHIR-44025 |
Clarify scope of catchment area |
| FHIR-44024 |
Clarify scope to include test RESULTS available in hospital system |
| FHIR-43823 |
Fix Update Capability Statement description |
| FHIR-43680 |
Data for the disease burden project are not anonymous to the RESP-NET site |
| FHIR-43679 |
Consider adding a hospital identifier |
| FHIR-43678 |
Section’s title should be changed for consistent terminology throughout |
| FHIR-43677 |
Can the system distinguish between patient discharge vs. patient transfer to another hospital? |
| FHIR-43676 |
Restate description for Use Cases 4 and 5 |
| FHIR-43675 |
Evaluate the consistency of using “case” |
| FHIR-43604 |
References to MedMorph create ambiguity |
| FHIR-43598 |
Subscription requirement |
| FHIR-43584 |
Focus IG on Knowledge and Content |
| FHIR-43534 |
Data Element Requirements |
| FHIR-43532 |
Editorial Updates in 7.1.1 CapabilityStatement |
| FHIR-43503 |
Clarify the Pregnancy Outcome entry |
| FHIR-43502 |
Content missing from the Composition profile narrative |
| FHIR-43500 |
Clarify placement of DiagnosticReport in the Composition |
| FHIR-43498 |
Possible duplicate entry in Composition narrative |
| FHIR-43497 |
Clarify use of MedicationReference slice |
| FHIR-43496 |
Clarify usage of Medication resources in Composition profile |
| FHIR-43495 |
Clarify the nature of requirements in the Composition profile narrative |
| FHIR-43493 |
Please confirm the use of the Composition.type LOINC code |
| FHIR-43492 |
Clarify the 72 hours threshold after encounter close |
| FHIR-43491 |
Missing word in Section 3.4.5 |
| FHIR-43490 |
Figure text overlaps a line |
| FHIR-43489 |
Inconsistency in COVID references |
| FHIR-43486 |
Clarify reporting requirement time frame |
| FHIR-43485 |
Alignment of Use Cases 1,2 and 3 |
| FHIR-43462 |
Clarify monitoring of positive patients |
| FHIR-43461 |
Remove references to BSA |